Add Company
Join Now

NeoLight Revenue and Competitors

License our Company Data API

Phoenix, AZ USA

Location

N/A

Total Funding

Medical Equip

Industry

Estimated Revenue & Valuation

  • NeoLight's estimated annual revenue is currently $13.8M per year.(i)
  • NeoLight's estimated revenue per employee is $251,000

Employee Data

  • NeoLight has 55 Employees.(i)
  • NeoLight grew their employee count by 49% last year.

NeoLight's People

NameTitleEmail/Phone
1
Co-Founder and Applied Research Engineer IIReveal Email/Phone
2
Co-Founder and Principal EngineerReveal Email/Phone
3
Co-founder & CEOReveal Email/Phone
4
Co-Founder and Principal EngineerReveal Email/Phone
5
VP Business DevelopmentReveal Email/Phone
6
VP Quality / RegulatoryReveal Email/Phone
7
VP Quality & Regulatory AffairsReveal Email/Phone
8
Senior Director Product & MarketingReveal Email/Phone
9
Director, ClinicalReveal Email/Phone
10
Director Supply Chain and ManufacturingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.8M5549%N/AN/A
#2
$9.8M390%N/AN/A
#3
$0.5M40%N/AN/A
#4
$20.3M8165%N/AN/A
#5
$10.8M430%N/AN/A
#6
$28.1M112-3%$83.2MN/A
#7
$6.5M260%N/AN/A
#8
$8M190%N/AN/A
#9
$11M576%N/AN/A
#10
$12M487%N/AN/A
Add Company

What Is NeoLight?

NeoLight is a modern medical device company that engineers, designs and manufactures technologies that treat infants with life threatening medical conditions. Our mission is to reinvent newborn health care through empathy-driven solutions. Our first product, the Skylifeâ„¢ Phototherapy System, is a cutting-edge portable device that treats neonatal jaundice, which affects many newborns worldwide. The Skylifeâ„¢ device represents the first in a line of products where putting the baby first drives the design and development.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$13.8M

Revenue (est)

49%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.2M5522%N/A
#2
$10.4M554%N/A
#3
$13.4M5520%N/A
#4
$10.5M55-2%N/A
#5
$7.4M5515%N/A